Clinical Trials

Sponsor: COG

Sponsor Study ID: ANBL1232

Study Title: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

NCT Number: NCT02176967

Phase: III

Protocol Type: Treatment

Age Group: Children

Disease Sites: Brain and Nervous System

Study Objectives:



Study Documents    
(MUSC NetID required for document access)